Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: VSV-ZEBOV Geneva Vaccine Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for VSV-ZEBOV showing completed status with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VSV-ZEBOV

Snippet

Sponsor: University Hospital, Geneva | Conditions: Ebolavirus Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-10